Health Catalyst Elevates Ben Albert to CEO, Board Downsized to Five Directors
Health Catalyst appointed President and COO Ben Albert as CEO effective February 12, 2026, accelerating its succession plan and transitioning Dan Burton to strategic advisor. The board will shrink from nine to five directors before the 2026 Annual Meeting following departures of Dawn Smith, Duncan Gallagher, John Kane and Matt Kolb.
1. Leadership Succession
Effective February 12, 2026, Ben Albert, formerly President and COO, assumes the role of CEO, accelerating the previously announced succession plan. Dan Burton steps down as CEO and board member but will remain with the company under a transition agreement as strategic advisor.
2. Board Restructuring
Health Catalyst is reducing its board to five directors immediately prior to the 2026 Annual Meeting. Dawn Smith and Duncan Gallagher departed on February 17, 2026, John Kane will exit on April 1, 2026, and Matt Kolb will not seek reelection, all to streamline governance.
3. Strategic Focus
With over 25 years in healthcare technology, Albert plans to sharpen focus on cost control, operational efficiency, clinical quality and consumer experience. Initial actions as COO included leadership restructuring and resource realignment toward the highest-return priorities to support a return to growth.